At a glance
ClinicalIndex Comparison RecordN/ACompleted· 150 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients
In Brief
An observational study for Uterine Cervical Neoplasms and Sexually Transmitted Diseases. Completed, enrolled 150 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the acceptability and effectiveness of utilizing vaginal self-swabs for HPV DNA testing as compared to provider-collected cervical swabs for HPV, as well as to investigate the prevalence of other Sexually Transmitted Infections (STIs) among sexually active female-to-male (FTM) transgender adults.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsPatient-Centered Outcomes Research Institute
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJan 2015
First PostedMar 2015
Primary CompletionSep 2016
TodayJul 2026
First PostedMar 30, 2015
Enrollment StartJan 1, 2015
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 11.3 years ago